Reprogramming is the conversion of a somatic cell to a pluripotent stem cell. This technique is now routinely used in laboratories around the world, but the vast majority of reprogrammed stem cell lines are not developmentally fully competent, compromising their utility in research and therapy. Reprogramming induces DNA damage, which can have lasting consequences on the quality of the resulting cells. Our studies have shown that DNA damage during reprogramming is induced by abnormalities in DNA replication. However, the cause of DNA damage, the mechanisms of repair, and the developmental consequences of the damage are not well understood. The strength of this proposal is that with the experimental systems used, we are able to identify the specific type of damage induced by reprogramming, and the molecular mechanisms required for repair: we are able to distinguish the role of double strand break HR from the role of stalled replication fork stability. We are also able to distinguish the effect of genome instability on reprogramming efficiency from incomplete transcriptional transitions. We are able to map the sites in the genome with reprogramming-induced damage, and we are able to identify pathways that can be used to increase genome stability and potentially improve developmental competence of reprogrammed stem cells. These studies will provide a mechanistic understanding how genome instability inhibits the induced transition between different cellular states.

Public Health Relevance

Pluripotent stem cells obtained from somatic cells are being used for the development of cell therapies, and are widely used in basic research. However, during the generation of these cells, the genome becomes unstable, which can result in compromised cell lines with genetic changes. The proposed research will lead us to understand how DNA damage forms during reprogramming, how it is repaired, and how it can be mitigated to generate cells of more consistent quality.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM132604-01A1
Application #
9973944
Study Section
Cellular Signaling and Regulatory Systems Study Section (CSRS)
Program Officer
Reddy, Michael K
Project Start
2020-09-01
Project End
2024-05-31
Budget Start
2020-09-01
Budget End
2021-05-31
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pediatrics
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032